Inici › Mieloma múltiple › Nova Jersey › Edison
Assaigs clínics de Mieloma múltiple a Edison, NJ
22 estudis de Mieloma múltiple busquen participants en centres de Edison i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
ReclutantFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 3
- Astera Cancer Care, East Brunswick · a 6 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ReclutantFase 3
- Astera Cancer Care, East Brunswick · a 6 mi
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
ReclutantFase 3
- MSK Basking Ridge, Basking Ridge · a 15 mi
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
ReclutantFase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
ReclutantFase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
ReclutantFase 3
- MSK Basking Ridge, Basking Ridge · a 15 mi
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
ReclutantFase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ReclutantFase 3
- Research Site, East Brunswick · a 6 mi
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
ReclutantEstudi observacional
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
ReclutantFase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
ReclutantFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
ReclutantFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
ReclutantFase 1 inicial
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · a 3 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
ReclutantFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · a 3 mi
A Dietary Study for People With Multiple Myeloma
Reclutant
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ReclutantFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
ReclutantFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Reclutant
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi
Assaigs de Mieloma múltiple en altres ciutats
- New York City, NY60 estudis
- Boston, MA42 estudis
- Atlanta, GA41 estudis
- Houston, TX38 estudis
- Durham, NC37 estudis
- Nashville, TN32 estudis
- Denver, CO27 estudis
- Rochester, MN24 estudis
- St. Louis, MO24 estudis
- Columbus, OH24 estudis
- Baldwin Park, CA23 estudis
- Chicago, IL22 estudis
Altres estudis a Edison
- Càncer de mama68 estudis
- Càncer de pulmó de cèl·lules no petites47 estudis
- Càncer (tots els tipus)33 estudis
- Càncer de pròstata29 estudis
- Càncer colorrectal23 estudis
- Càncer de pulmó23 estudis
- Càncer de bufeta21 estudis
- Càncer metastàtic20 estudis
- Càncer d'ovari20 estudis
- Leucèmia mieloide aguda20 estudis
- Càncer d'endometri19 estudis
- Carcinoma urotelial (de cèl·lules de transició)18 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.